For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029. This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players of CAR-T and TCR-T Cell Therapy as well as some small players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Applications Segment:
- Hematologic Malignancies
- Solid Tumors
Companies Covered:
- Kite Pharma Inc./Gilead
- Juno Therapeutics Inc./Bristol-Myers Squibb
- TCR2 Therapeutics Inc.
- Poseida Therapeutics Inc.
- Immatics N.V.
- Instil Bio Inc.
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Kite Pharma Inc./Gilead
- Juno Therapeutics Inc./Bristol-Myers Squibb
- TCR2 Therapeutics Inc.
- Poseida Therapeutics Inc.
- Immatics N.V.
- Instil Bio Inc.

